Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.
Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter I
|
GENERIC NAME |
TRADE NAME |
CONDITION |
STUDY CODE |
STUDY NAME |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
|---|---|---|---|---|---|---|
|
IDRABIOTAPARINUX |
Not Marketed |
Deep Venous Thrombosis |
EFC5945 |
EQUINOX |
||
|
IDRABIOTAPARINUX |
Not Marketed |
Deep Venous Thrombosis |
EFC6034 |
CASSIOPEA |
||
|
IDRABIOTAPARINUX |
Not Marketed |
Deep Venous Thrombosis |
EFC10295 |
BOREALIS-AF |
||
|
IKK INHIBITOR |
Not Marketed |
Osteoarthritis |
ACT12505 |
NA |
||
|
IKK INHIBITOR |
Not Marketed |
Osteoarthritis |
TDU10820 |
NA |
||
|
IKK INHIBITOR |
Not Marketed |
Osteoarthritis |
TDU11333 |
NA |
||
|
IKK INHIBITOR |
Not Marketed |
Osteoarthritis |
TDU11685 |
NA |
||
|
IMIGLUCERASE |
Cerezyme |
Gaucher Disease |
CZ-011-01 |
NA |
||
|
IMIGLUCERASE |
Cerezyme |
Gaucher Disease |
RC 91-0110* |
NA |
|
|
|
IMIGLUCERASE |
Cerezyme |
Gaucher Disease |
RC 92-0301* |
NA |
|
|
|
IMIGLUCERASE |
Cerezyme |
Gaucher Disease |
RC 92-0501* |
NA |
|
|
|
IMIGLUCERASE |
Cerezyme |
Gaucher Disease |
RC96-1101* |
NA |
||
|
INIPARIB |
Not Marketed |
Peritoneal and Ovarian Cancer |
ARD11489 |
NA |
||
|
INIPARIB |
Not Marketed |
Advanced solid tumors |
BEX11505 |
NA |
||
|
INIPARIB |
Not Marketed |
Breast Cancer |
EFC11486 |
NA |
||
|
INIPARIB |
Not Marketed |
Breast Cancer |
EFC11614 |
NA |
||
|
INIPARIB |
Not Marketed |
Cancer |
LTS12674 |
NA |
||
|
INIPARIB |
Not Marketed |
Breast Cancer |
TCD11418 |
NA |
||
|
INIPARIB |
Not Marketed |
Breast Cancer |
TCD11419 |
SOLTI NeoPARP |
||
|
INIPARIB |
Not Marketed |
Advanced solid tumors |
TCD11484 |
NA |
||
|
INIPARIB |
Not Marketed |
Breast Cancer |
TCD11485 |
NA |
||
|
INIPARIB |
Not Marketed |
Breast Cancer |
TCD11487 |
NA |
||
|
INIPARIB |
Not Marketed |
Ovarian Cancer |
TCD11503 |
NA |
||
|
INIPARIB |
Not Marketed |
Ovarian Cancer |
TCD11504 |
NA |
||
|
INIPARIB |
Not Marketed |
Breast Cancer |
TCD11608 |
NA |
||
|
INIPARIB |
Not Marketed |
Uterine Carcinosarcoma |
TCD11615 |
NA |
||
|
INIPARIB |
Not Marketed |
Malignant Glioma |
TCD11616 |
NA |
||
|
INIPARIB |
Not Marketed |
Neoplasm malignant |
TED11746 |
NA |
||
|
INIPARIB |
Not Marketed |
Advanced solid tumors |
TED11451 |
NA |
||
|
INIPARIB |
Not Marketed |
Non-small cell lung cancer |
EFC11553 |
NA |
||
|
INIPARIB |
Not Marketed |
Non-small cell lung cancer |
TCD11420 |
NA |
||
|
INSULIN ASPART |
Insulin aspart Sanofi |
Diabetes Mellitus, Type 1 and 2 |
EFC15081 |
GEMELLI 1 |
||
|
INSULIN ASPART |
Insulin aspart Sanofi |
Diabetes Mellitus，Type 1 |
PDY12695 |
NA |
||
|
INSULIN ASPART |
Insulin aspart Sanofi |
Diabetes Mellitus, Type 1 and 2 |
PDY15083 |
NA |
||
|
INSULIN ASPART |
Insulin aspart Sanofi |
Diabetes Mellitus, Type 1 and 2 |
PDY15084 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
EFC11202 |
PRESCHOOL |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
EXT_LANTU_C_02761 |
EASIE EXTENSION |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 2 |
HOE901/4002 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 2 |
HOE901_3504 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 1 |
HOE901_3505 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_3506 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
HOE901_3507 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_3509 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4014 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
HOE901_4019 |
NA |
NA |
|
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4020 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4022 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
HOE901_4023 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 2 |
HOE901_4027 |
LAPTOP |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
HOE901_4028 |
S.A.M. |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 and 2 |
HOE901_4030 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
HOE901_4036 |
PUMP |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 and 2 |
HOE901_4038 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 2 |
HOE901_4039 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 2 |
HOE901_4040 |
APOLLO |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 2 |
HOE901_4041 |
INITIATE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4042 |
TULIP |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4043 |
GALATEE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4045 |
GOT |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
HOE901_4046 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes, Type 2 |
HOE901_4049 |
SAFIR |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4050 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4052 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4053 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4055 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4057 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_4059 |
LANTUSTITR |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
HOE901_5007 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
HOE901_5036 |
ROLLING WAVES |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_C_00579 |
L2T3 |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_C_02761 |
EASIE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 and 2 |
LANTU_L_00722 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus Type 2 |
LANTU_L_01051 |
NA |
NA |
|
|
INSULIN GLARGINE |
Lantus |
Myocardial Infarction |
LANTU_L_01687 |
INTENSIVE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_01890 |
DOMME |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_02193 |
BETA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_02670 |
LOHAS |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_02673 |
CONBIN2 |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_02756 |
OPTIMIZATION |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_02936 |
MALBEC |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_03502 |
LANTIT |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04264 |
RELIANCE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04572 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTUL07225 |
NEWLAN |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LTS6036 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
PKD11627 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
TDR11626 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
PKD12270 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LTS6035 |
ORIGIN |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_C_04589 |
GALAPAGOS |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_05191 |
PEN PREFERENCE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04211 |
LanScape |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04695 |
START |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
APIDR_L_04717 |
BASAAL PLUS |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04867 |
B to B |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_R_05048 |
CHANGING |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_C_02762 |
LANCELOT |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_R_04889 |
ATLAS |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04079 |
HAPPY |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
APIDR_L_04884 |
NA |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_C_03680 |
EAGLE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
LANTU_R_05033 |
SUBSTITUTE |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04980 |
AFICIONADO |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_04737 |
DINAMO |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
EFC11681 |
Lantus-P-CN |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTUL06638 |
TED |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTU_L_05146 |
SeLan |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTUL07190 |
BEYOND III/ FPG GOAL |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTUL07191 |
Glargine Starting dose |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 2 |
LANTUL07194 |
SWITCH |
||
|
INSULIN GLARGINE |
Lantus |
Diabetes Mellitus, Type 1 |
LANTUL08473 |
SHINE |
||
|
INSULIN GLARGINE |
Lantus Solostar |
Diabetes Mellitus, Type 2 |
LANTU_L_05477 |
GAUDI |
||
|
INSULIN GLARGINE |
Not marketed |
Diabetes Mellitus, Type 1 |
PDY13928 |
NA |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
ACT12374 |
NA |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 1 |
BDR10880 |
NA |
|
|
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 1 |
BDR11038 |
NA |
|
|
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 1 |
BDR11578 |
NA |
|
|
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
EFC12404 |
Lixi-Lan-O |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
EFC12405 |
Lixi-Lan-L |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
EFC13794 |
LixiLan-G |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
EFC14112 |
LIXILAN JP-O1 |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
EFC14113 |
LIXILAN JP-L |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
EFC14114 |
LIXILAN JP-O2 |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
INSLIL08556 |
LixiLan-India |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
LPS14860 |
LixiLan-D |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
LPS15017 |
Global Premix |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
LPS15544 |
LixilanOne CAN |
||
|
INSULIN GLARGINE |
Soliqua |
Diabetes Mellitus, Type 2 |
PDY14115 |
NA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
EFC13957 |
EDITION JUNIOR |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
LPS14585 |
NA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
LPS15396 |
ARTEMIS-DM |
||
|
IINSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
OBS14708 |
ATOS |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
PKD13560 |
NA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
PDY12335 |
NA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
EFC11628 |
EDITION I |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
EFC11629 |
EDITION II |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
EFC12449 |
EDITION JP I |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
EFC12512 |
EDITION JP II |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
EFC12347 |
EDITION III |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
EFC12456 |
EDITION IV |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
PDY14065 |
NA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
GLARGL07496 |
TITRATION |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
GLARGL07537 |
Italian Titration Approach Study |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
GLARGL07667 |
Transition II |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
LPS14584 |
BRIGHT |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
LPS14587 |
NA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
LPS13931 |
REACH CONTROL |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
LPS14060 |
REACH CONTROL |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
GLARGL07921 |
EASE |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
EFC13799 |
SENIOR |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
LPS14409 |
TAKE Control |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
PDY12777 |
NA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
GLARGL07699 |
OPTIMIZE |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
GLARGL08200 |
TOP1 |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 1 |
MSC15146 |
eStudy |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
EFC12814 |
EDITION AP |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
GLARGL07710 |
COBALTA |
||
|
INSULIN GLARGINE NEW FORMULATION |
Toujeo |
Diabetes Mellitus, Type 2 |
LPS14347 |
ACHIEVE CONTROL REAL LIFE STUDY PROGRAM |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
APIDR_L_04884 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
APIDR_L_04717 |
BASAAL PLUS |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
APIDR_C_01160 |
NA |
NA |
|
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
APIDR_C_02083 |
PUMP |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
APIDR_L_00041 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 and 2 |
APIDR_L_00348 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
APIDR_L_01913 |
SCALE |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
APIDR_L_02483 |
PORTAL1 |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
BEQ13941 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes, Type 1 |
EFC6096 (HMR1964D-3001) |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes, Type 1 |
EFC6167 (HMR1964A/3101) |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes, Type 2 |
EFC6168 (HMR1964A/3102) |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
HMR1964A_1501 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_1502 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_1505 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3502 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3503 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3504 |
GINGER |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
HMR1964A_3505 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
HMR1964A_3505UA |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3506 |
OSIRIS |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3507 |
OPAL |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 and 2 |
HMR1964A_3508 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3511 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3514 |
ELEONOR |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_3515 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
HMR1964A_3516 |
VARIABILITE |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 1 |
HMR1964A_3517 |
NA |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
HMR1964A_4002 |
BASAL PLUS |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
LANTU_L_04211 |
LanScape |
||
|
INSULIN GLULISINE |
Apidra |
Diabetes Mellitus, Type 2 |
LANTU_L_04695 |
START |
||
|
INSULIN HUMAN |
Insuman Comb 25 |
Diabetes Mellitus, Type 2 |
HUBIN_L_05574 |
SPIRIT |
||
|
INSULIN HUMAN |
Insuman Comb 25 |
Diabetes Mellitus, Type 2 |
EFC12059 |
Insuman-C25-CN |
||
|
INSULIN HUMAN |
Insuplant |
Diabetes Mellitus, Type 1 |
HUBIN_L_05335 |
HUBIN |
||
|
INSULIN LISPRO |
Admelog |
Diabetes Mellitus, Type 1 |
EFC12619 |
SORELLA 1 |
||
|
INSULIN LISPRO |
Admelog |
Diabetes Mellitus, Type 2 |
EFC13403 |
SORELLA 2 |
||
|
INSULIN LISPRO |
Admelog |
Diabetes Mellitus, Type 1 |
PDY12704 |
NA |
||
|
INSULIN LISPRO |
Admelog |
Diabetes Mellitus, Type 1 |
PDY13502 |
NA |
||
|
INSULIN LISPRO |
Not marketed |
Diabetes Mellitus, Type 1 |
BEQ15846 |
NA |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
IRBES_L_00165 |
I SAVE |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
IRBES_L_00907 |
NA |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
L_8261 |
NA |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
L_8484 |
APROVE TUNISIE |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
L_8759 |
NA |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
L_8793 |
APROVE ALGERIE |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
L_8829 |
NA |
||
|
IRBESARTAN |
Aprovel |
Cardiovascular Risk Factors |
L_9079 |
PRIME |
||
|
IRBESARTAN |
Aprovel |
Cardiovascular Risk Factors |
L_9130 |
IREDIS |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
L_9917 |
NO PROBLEM |
||
|
IRBESARTAN |
Aprovel |
Hypertension, Arterial |
PM_C_0024 |
ARCHIPELAGO |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
PM_L_0255 |
I SELECT |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
PM_L_0256 |
I PREVENT |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
R_8791 |
AMISH |
||
|
IRBESARTAN |
Aprovel |
Hypertension |
R_9511 |
RIAT |
||
|
IRBESARTAN + AMLODIPINE |
Aprovasc |
Hypertension |
IRBAM_R_04219 |
I-ADD |
||
|
IRBESARTAN + AMLODIPINE |
Aprovasc |
Hypertension |
IRBAM_R_04220 |
I-COMBINE |
||
|
IRBESARTAN + AMLODIPINE |
Aprovasc |
Hypertension |
IRBES_R_04320 |
I COMBO |
||
|
IRBESARTAN + AMLODIPINE |
Aprovasc |
Hypertension |
IRBES_L_05887 |
NA |
||
|
IRBESARTAN + HYDROCHLOROTHIAZIDE |
Co Aprovel |
Hypertension |
IRBEH_L_00702 |
NA |
||
|
IRBESARTAN + HYDROCHLOROTHIAZIDE |
Co Aprovel |
Hypertension |
IRBEH_L_03170 |
INCENT |
||
|
IRBESARTAN + HYDROCHLOROTHIAZIDE |
Co Aprovel |
Hypertension |
IRBEH_R_02584 |
COSIMA2 |
||
|
IRBESARTAN + HYDROCHLOROTHIAZIDE |
Co Aprovel |
Hypertension |
IRBEH_R_02931 |
ACTUAL |
||
|
IRBESARTAN + HYDROCHLOROTHIAZIDE |
Co Aprovel |
Hypertension |
L_9292 |
NA |
||
|
IRBESARTAN + HYDROCHLOROTHIAZIDE |
Co Aprovel |
Hypertension |
PM_L_0094 |
NA |
||
|
ISATUXIMAB |
NA |
Lymphoma or Leukemia |
ACT14596 |
ISLAY |
||
|
ISATUXIMAB |
Not marketed |
Prostate Cancer or Non-small Cell Lung Cancer |
ACT15319 |
NA |
||
|
ISATUXIMAB |
Not marketed |
Plasma Cell Myeloma |
TCD14079 |
PomdeSAR |
||
|
ITEPEKIMAB |
Not marketed |
Asthma |
ACT15102 |
NA |
||
|
ITEPEKIMAB |
Not marketed |
Asthma |
ACT15104 |
NA |
References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted